Having new molecules will give doctors more options to select a drug that caters precisely to individual patients needs. CORRECTION This story was updated on April 10, 2026, to correctly describe the intended dosing of the injectable amylin-mimicking weight-loss drug being developed by Alveus Therapeutics
Its getting a lot of attention because it could be a big help for those who struggle with being overweight
Comparison Search Melanotan 2 vs PT-141: two melanocortin peptides, two worlds They are often confused, and that's a mistake
Alterations of Gpx4 and Acsl4 expression after sulfasalazine treatment
Phentermine and Adderall act on similar brain chemicals but are not interchangeable
Researchers said the study backs up anecdotal evidence from patients and doctors that semaglutide can lead to a sudden loss of longing for alcoholic drinks, and adds to a growing body of evidence that the drug may have benefits beyond weight loss or controlling diabetes